4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000049
CEO bought 32,000 shares at an average $0.01 ($288)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-06 | Purchase : show line 1 in the form | +5,000 | $0.01 | $46 | 25,303,297 | D |
| 2019-09-06 | Purchase : show line 2 in the form | +5,000 | $0.01 | $46 | 25,308,297 | D |
| 2019-09-06 | Purchase : show line 3 in the form | +5,000 | $0.01 | $46 | 25,313,297 | D |
| 2019-09-09 | Purchase : show line 4 in the form | +2,000 | $0.01 | $20 | 25,315,297 | D |
| 2019-09-09 | Purchase : show line 5 in the form | +5,000 | $0.01 | $41 | 25,320,297 | D |
| 2019-09-09 | Purchase : show line 6 in the form | +2,000 | $0.01 | $17 | 25,322,297 | D |
| 2019-09-10 | Purchase : show line 7 in the form | +2,000 | $0.01 | $19 | 25,324,297 | D |
| 2019-09-10 | Purchase : show line 8 in the form | +2,000 | $0.01 | $19 | 25,326,297 | D |
| 2019-09-11 | Purchase : show line 9 in the form | +2,000 | $0.01 | $17 | 25,328,297 | D |
| 2019-09-11 | Purchase : show line 10 in the form | +2,000 | $0.01 | $18 | 25,330,297 | D |
| Open-market purchases · 32,000 sh · avg $0.01 · $288 | ||||||
Loading xslF345X03/primary_doc.xml…